NurrOn Pharmaceuticals welcomes Dr. Almira Chabi to its Board of Directors
– SOUTH KOREA, Seoul – NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson’s disease and other Nurr1-related human disorders, today announced the appointment of Dr.…